KB to arrange financing for Kolmar Korea’s pharma business acquisition IMM PE has selected KB Securities and KB Kookmin Bank to arrange acquisition financing
Translated by Kim So-in 공개 2020-05-07 08:00:11
이 기사는 2020년 05월 07일 08:00 thebell 에 표출된 기사입니다.
South Korea’s IMM Private Equity (IMM PE) has selected KB Securities and KB Kookmin Bank to arrange financing for its purchase of Kolmar Korea’s pharmaceutical business.The PE firm is currently negotiating the final price with the seller, Kolmar Korea Holdings, sources familiar with the matter said on April 29.
IMM PE has outlined funding plan for the acquisition. The PE firm plans to fund around 50 percent of the acquisition price by using acquisition financing, which will be jointly arranged by KB Securities and KB Kookmin Bank. The amount of the acquisition financing may vary depending on the final price.
Separately, the PE firm is likely to fund the remaining amount through its flagship fund RoseGold 4, whose fund size is more than two trillion won.
Kolmar Korea Holdings has agreed to sell Kolmar Korea’s pharmaceutical unit and its entire stake in Kolmarpharma to IMM PE for 750 billion won. Kolmar Korea Holdings and IMM PE are expected to sign a stock purchase agreement in the near term.
KB Securities and KB Kookmin Bank have reportedly been hired as arrangers by providing debt financing with attractive terms. IMM PE is said to have targeted Kolmar Korea’s pharmaceutical business assets because of the business model, in which Kolmar Korea offers contract manufacturing services to local pharmaceutical companies.
The latest deal is expected to help KB Securities build a solid track record. The brokerage firm arranged acquisition financing of several deals worth multi trillion won, including Macquarie Asia Infrastructure Fund’s acquisition of Daesung Industrial Gases and Macquarie Korea Opportunities Management (Macquarie PE)’s acquisition of a stake in LG CNS. KB Kookim Bank also jointly arranged acquisition financing for the LG CNS deal. The lender arranged acquisition financing of IMM Investment’s one trillion won investment in U.S.-based Texas Express Pipeline at the end of last year.
(By reporter Kim Hye-ran)
< 저작권자 ⓒ 자본시장 미디어 'thebell', 무단 전재, 재배포 및 AI학습 이용 금지 >
관련기사
best clicks
최신뉴스 in 전체기사
-
- [코스닥 코스메틱 리뉴얼]마스크팩 잘나가던 지피클럽, 색조화장 '코디 인수'
- [K-배터리 밸류업 리포트]'오너 경영체제' 원준, 승계작업 '언제쯤'
- [thebell note]제약바이오는 다이어트 중
- [바이오텍 유증·메자닌 승부수]브릿지바이오, 유무상증자에 '대표 지분 블록딜' 왜?
- [제일약품의 온코닉테라퓨틱스 첫 '신약']성장성·사업성 갖춘 IPO 기대주 '밸류업' 이유 더 있다
- [코스닥 리빌딩 리포트]'조달 지연' 비투엔, 불성실공시법인 지정 가능성은
- [Board Index/네이버]사외이사 정보제공 '정조준'…교육도 대폭 늘려
- "35년 영업맨, 상장 후 글로벌 시장 노린다"
- [아시아나 화물사업부 M&A]LOC 낸 에어인천·이스타, LOI 낸 에어프레미아
- SK하이닉스의 20조 투자 자신감 '엔비디아 선급금'